Loading, please wait...

product description page

Interleukin 12 : Antitumor Activity and Immunotherapeutic Potential in Oncology (Paperback) (Witold

Interleukin 12 : Antitumor Activity and Immunotherapeutic Potential in Oncology (Paperback) (Witold - image 1 of 1

About this item

This book discusses the immunotherapeutic potential of Interleukin 12 in the context of clinical oncology, as well as antitumor effects confirmed in preclinical studies and clinical trials in cancer immunotherapy. Due to its ability to activate both innate (NK cells) and adaptive (cytotoxic T lymphocytes) immunities, Interleukin 12 (IL-12) has been regarded as a promising candidate for tumor immunotherapy. However, despite the encouraging results in animal models, only very modest antitumor effects have been confirmed in early clinical trials. Recently, several clinical studies have been initiated in which IL-12 was applied as an adjuvant in cancer vaccines, in gene therapy including locoregional injections of IL-12 plasmid, and in the form of tumor-targeting immunocytokines (IL-12 fused to monoclonal antibodies)

Genre: Medical, Science
Series Title: Springerbriefs in Immunology
Format: Paperback
Publisher: Springer Verlag
Author: Witold Lasek
Language: English
Street Date: October 28, 2016
TCIN: 51717321
UPC: 9783319469058
Item Number (DPCI): 248-33-2536
If the item details above aren’t accurate or complete, we want to know about it. Report incorrect product info.

Guest reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.